Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies

Virchows Archiv

Volumn 449, Issue 4, 2006, Pages 421-427

  Schulz, Solveig ^a   Röcken, Christoph ^a,b   Schulz, Stefan ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antibody; Bombesin; Bombesin receptor; BRS 3; GRP R; Immunocytochemistry; Neoplasm; Western blot

Indexed keywords

BOMBESIN; BOMBESIN RECEPTOR; BOMBESIN RECEPTOR SUBTYPE 3; FORMALDEHYDE; G PROTEIN COUPLED RECEPTOR; GASTRIN RELEASING PEPTIDE PREFERRING BOMBESIN RECEPTOR; PARAFFIN; PEPTIDE ANTIBODY; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADSORPTION; ANTIBODY SPECIFICITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER RADIOTHERAPY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN LOCALIZATION; RECEPTOR BINDING; TUMOR CELL; TUMOR DIAGNOSIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDES; RABBITS; RECEPTORS, BOMBESIN; TUMOR MARKERS, BIOLOGICAL;

EID: 33748987928     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0265-7     Document Type: Article

References (42)

1. Anastasi A, Erspamer V, Bucci M (1971) Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27:166-167
2. Bold RJ, Ishizuka J, Yao CZ, Townsend CM Jr, Thompson JC (1998) Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status. Anticancer Res 18:4051-4056
3. Breeman WA, De Jong M, Bernard BF, Kwekkeboom DJ, Srinivasan A, van der Pluijm ME, Hofland LJ, Visser TJ, Krenning EP (1999) Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy. Int J Cancer 83:657-663
4. Breeman WA, Hofland LJ, de Jong M, Bernard BF, Srinivasan A, Kwekkeboom DJ, Visser TJ, Krenning EP (1999) Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy. Int J Cancer 81:658-665
5. Carroll RE, Matkowskyj KA, Chakrabarti S, McDonald TJ, Benya RV (1999) Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. Am J Physiol 276:G655-665
6. Carroll RE, Ostrovskiy D, Lee S, Danilkovich A, Benya RV (2000) Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines. Mol Pharmacol 58:601-607
7. Chave HS, Gough AC, Palmer K, Preston SR, Primrose JN (2000) Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa. Br J Cancer 82:124-130
8. Engel JB, Keller G, Schally AV, Halmos G, Hammann B, Nagy A (2005) Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215. Clin Cancer Res 11:2408-2415
9. Engel JB, Schally AV, Halmos G, Baker B, Nagy A, Keller G (2005) Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins. Endocr Relat Cancer 12:999-1009
10. Fleischmann A, Laderach U, Friess H, Buechler MW, Reubi JC (2000) Bombesin receptors in distinct tissue compartments of human pancreatic diseases. Lab Invest 80:1807-1817
11. Fleischmann A, Waser B, Gebbers JO, Reubi JC (2005) Gastrinreleasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. J Clin Endocrinol Metab 90:4722-4729
12. Gugger M, Reubi JC (1999) Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol 155:2067-2076
13. Kahan Z, Sun B, Schally AV, Arencibia JM, Cai RZ, Groot K, Halmos G (2000) Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II. Cancer 88:1384-1392
14. Keller G, Schally AV, Nagy A, Halmos G, Baker B, Engel JB (2005) Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas. Cancer 104:2266-2274
15. Kiaris H, Schally AV, Nagy A, Sun B, Armatis P, Szepeshazi K (1999) Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice. Br J Cancer 81:966-971
16. Kroog GS, Jensen RT, Battey JF (1995) Mammalian bombesin receptors. Med Res Rev 15:389-417
17. Markwalder R, Reubi JC (1999) Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res 59:1152-1159
18. McDonald TJ, Jornvall H, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V (1979) Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 90:227-233
19. Minamino N, Kangawa K, Matsuo H (1983) Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun 114:541-548
20. Moody TW, Mantey SA, Pradhan TK, Schumann M, Nakagawa T, Martinez A, Fuselier J, Coy DH, Jensen RT (2004) Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells. J Biol Chem 279:23580-23589
21. Mundschenk J, Unger N, Schulz S, Hollt V, Steinke R, Lehnert H (2003) Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. J Clin Endocrinol Metab 88:5150-5157
22. Nagalla SR, Barry BJ, Creswick KC, Eden P, Taylor JT, Spindel ER (1995) Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4). Proc Natl Acad Sci USA 92:6205-6209
23. Nock BA, Nikolopoulou A, Galanis A, Cordopatis P, Waser B, Reubi JC, Maina T (2005) Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study. J Med Chem 48:100-110
24. Ohki-Hamazaki H, Iwabuchi M, Maekawa F (2005) Development and function of bombesin-like peptides and their receptors. Int J Dev Biol 49:293-300
25. Pfeiffer M, Koch T, Schroder H, Klutzny M, Kirscht S, Kreienkamp HJ, Hollt V, Schulz S (2001) Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst (3) receptor function by heterodimerization with sst(2A). J Biol Chem 276:14027-14036
26. Plonowski A, Nagy A, Schally AV, Sun B, Groot K, Halmos G (2000) In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215. Int J Cancer 88:652-657
27. Reubi JC, Waser B (2003) Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging 30:781-793
28. Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M (2002) Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). Clin Cancer Res 8:1139-1146
29. Reubi JC, Korner M, Waser B, Mazzucchelli L, Guillou L (2004) High expression of peptide receptors as a novel target in gastrointestinal stromal tumours. Eur J Nucl Med Mol Imaging 31:803-810
30. Reubi JC, Macke HR, Krenning EP (2005) Candidates for peptide receptor radiotherapy today and in the future. J Nucl Med 46 (Suppl 1):67S-75S
31. Ryan RR, Weber HC, Mantey SA, Hou W, Hilburger ME, Pradhan TK, Coy DH, Jensen RT (1998) Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells. J Pharmacol Exp Ther 287:366-380
32. Schulz S, Pauli SU, Handel M, Dietzmann K, Firsching R, Hollt V (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6:1865-1874
33. Schulz S, Rocken C, Mawrin C, Weise W, Hollt V (2004) Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Clin Cancer Res 10:8235-8242
34. Schulz S, Rocken C, Mawrin C (2005) Immunohistochemical localization of CCK1 cholecystokinin receptors in normal and neoplastic human tissues. J Clin Endocrinol Metab 90:6149-6155
35. Scopinaro F, Di Santo GP, Tofani A, Massari R, Trotta C, Ragone M, Archimandritis S, Varvarigou AD (2005) Fast cancer uptake of 99mTc-labelled bombesin (99mTc BN1). In Vivo 19:1071-1076
36. Smith CJ, Volkert WA, Hoffman TJ (2003) Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update. Nucl Med Biol 30:861-868
37. Smith CJ, Volkert WA, Hoffman TJ (2005) Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes. Nucl Med Biol 32:733-740
38. Stangelberger A, Schally AV, Varga JL, Zarandi M, Cai RZ, Baker B, Hammann BD, Armatis P, Kanashiro CA (2005) Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-Jun intracellular signalling. Eur J Cancer 41:2735-2744
39. Sun B, Halmos G, Schally AV, Wang X, Martinez M (2000) Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. Prostate 42:295-303
40. Sun B, Schally AV, Halmos G (2000) The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers. Regul Pept 90:77-84
41. Van de Wiele C, Dumont F, Vanden Broecke R, Oosterlinck W, Cocquyt V, Serreyn R, Peers S, Thornback J, Slegers G, Dierckx RA (2000) Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study. Eur J Nucl Med 27:1694-1699
42. Zhang H, Chen J, Waldherr C, Hinni K, Waser B, Reubi JC, Maecke HR (2004) Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors. Cancer Res 64:6707-6715